Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ASCO 2015: Pre-conference review

This article was originally published in Scrip

In this roundtable The Pink Sheet’s Mary Jo Laffler talks to experts from Datamonitor Healthcare, Citeline and BioMedTracker about their top picks from this year's ASCO abstracts, as well as other news to watch out for at the 2015 conference at the end of this month.

They discuss highlights in the area of immune-oncology, specifically new combination drug candidates; game-changing data expected for myeloma therapies; how companies are looking at new approaches for old targets in oncology; and more.

ASCO 2015 Pre-Conference Review from Datamonitor Healthcare on Vimeo.

Related stories:

Big pharma's immunotherapy game at ASCO

Good, Bad, Ugly: the ASCO abstracts are out

For more coverage on ASCO 2015:

The Pink Sheet





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts